Seeing Is Believing

Currently out of the existing stock ratings of Suraj Kalia, 119 are a BUY (73.91%), 20 are a HOLD (12.42%), 22 are a SELL (13.66%).
Analyst Suraj Kalia, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 56.68% that have a potential upside of 34.19% achieved within 200 days.
Suraj Kalia’s has documented 364 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EW, Edwards Lifesciences Corp at 07-Oct-2025.
Analyst best performing recommendations are on ISR (ISORAY).
The best stock recommendation documented was for ATRC (ATRICURE) at 4/28/2021. The price target of $75 was fulfilled within 1 day with a profit of $5.15 (7.37%) receiving and performance score of 73.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$388
$6.98 (1.83%)
$355
2 years 11 months 29 days ago
(01-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold
$380
$-1.02 (-0.27%)
$235
2 years 11 months 29 days ago
(01-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold
$380
$-1.02 (-0.27%)
$350
2 years 11 months 30 days ago
(31-Oct-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
$300
$-81.02 (-21.26%)
$425
3 years 18 days ago
(12-Oct-2022)
1/2 (50%)
$41.92 (16.24%)
19
Sell
$235
$-146.02 (-38.32%)
$275
3 years 3 months 16 days ago
(14-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
143
Which stock is Suraj Kalia is most bullish on?
Which stock is Suraj Kalia is most reserved on?
What Year was the first public recommendation made by Suraj Kalia?